182 related articles for article (PubMed ID: 29526175)
1. [Impact of Cystic Fibrosis Transmembrane Conductance Regulator on Malignant
Properties of KRAS Mutant Lung Adenocarcinoma A549 Cells].
Li H; Wang Y; Yang J; Liu X; Shi J
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):89-98. PubMed ID: 29526175
[TBL] [Abstract][Full Text] [Related]
2. Nicotine Induces Progressive Properties of Lung Adenocarcinoma A549 Cells by Inhibiting Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Expression and Plasma Membrane Localization.
Li H; Ma N; Wang J; Wang Y; Yuan C; Wu J; Luo M; Yang J; Chen J; Shi J; Liu X
Technol Cancer Res Treat; 2018 Jan; 17():1533033818809984. PubMed ID: 30384810
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus‑mediated overexpression of cystic fibrosis transmembrane conductance regulator enhances invasiveness and motility of serous ovarian cancer cells.
Xu J; Lin L; Yong M; Dong X; Yu T; Hu L
Mol Med Rep; 2016 Jan; 13(1):265-72. PubMed ID: 26549617
[TBL] [Abstract][Full Text] [Related]
4. Sox2 inhibits Wnt-β-catenin signaling and metastatic potency of cisplatin-resistant lung adenocarcinoma cells.
He J; Shi J; Zhang K; Xue J; Li J; Yang J; Chen J; Wei J; Ren H; Liu X
Mol Med Rep; 2017 Apr; 15(4):1693-1701. PubMed ID: 28259951
[TBL] [Abstract][Full Text] [Related]
5. CFTR inhibits the invasion and growth of esophageal cancer cells by inhibiting the expression of NF-κB.
Li W; Wang C; Peng X; Zhang H; Huang H; Liu H
Cell Biol Int; 2018 Dec; 42(12):1680-1687. PubMed ID: 30358020
[TBL] [Abstract][Full Text] [Related]
6. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells].
Zhou D; Wang J; Yang K; Zhang L; Zheng Q; Bai J; Hu Y; Mu Q; Yin C; Li H
Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):638-645. PubMed ID: 32838486
[TBL] [Abstract][Full Text] [Related]
8. DNA Methylation-Mediated Low Expression of CFTR Stimulates the Progression of Lung Adenocarcinoma.
Wang Y; Tang L; Yang L; Lv P; Mai S; Xu L; Wang Z
Biochem Genet; 2022 Apr; 60(2):807-821. PubMed ID: 34498165
[TBL] [Abstract][Full Text] [Related]
9. [Effects of heme oxygenase-1 knockdown on proliferation, invasion and metastasis of lung adenocarcinoma A549 cells and its mechanism].
Cao L; Suo XJ; Jiang W; Zhao D; Yan XJ; Yang J; Ma ZY
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):813-819. PubMed ID: 31770847
[No Abstract] [Full Text] [Related]
10. The cystic fibrosis transmembrane conductance regulator as a biomarker in non-small cell lung cancer.
Li J; Zhang JT; Jiang X; Shi X; Shen J; Feng F; Chen J; Liu G; He P; Jiang J; Tsang LL; Wang Y; Rosell R; Jiang L; He J; Chan HC
Int J Oncol; 2015 May; 46(5):2107-15. PubMed ID: 25760446
[TBL] [Abstract][Full Text] [Related]
11. IKKβ Kinase Promotes Stemness, Migration, and Invasion in KRAS-Driven Lung Adenocarcinoma Cells.
Rodrigues FS; Miranda VS; Carneiro-Lobo TC; Scalabrini LC; Kruspig B; Levantini E; Murphy DJ; Bassères DS
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823550
[TBL] [Abstract][Full Text] [Related]
12. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-RMRP Acts as an Oncogene in Lung Cancer.
Meng Q; Ren M; Li Y; Song X
PLoS One; 2016; 11(12):e0164845. PubMed ID: 27906963
[TBL] [Abstract][Full Text] [Related]
14. JAK2 variations and functions in lung adenocarcinoma.
Xu Y; Jin J; Xu J; Shao YW; Fan Y
Tumour Biol; 2017 Jun; 39(6):1010428317711140. PubMed ID: 28639892
[TBL] [Abstract][Full Text] [Related]
15. Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.
Li P; Liu H; Zhang Z; Lv X; Wang H; Ma J; Ma Z; Qu X; Teng YE
Med Sci Monit; 2018 Jan; 24():623-635. PubMed ID: 29384143
[TBL] [Abstract][Full Text] [Related]
16. The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol.
Albayrak G; Korkmaz FD; Tozcu D; Dogan Turacli I
J Cell Biochem; 2019 Jun; 120(6):10564-10571. PubMed ID: 30628735
[TBL] [Abstract][Full Text] [Related]
17. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
[TBL] [Abstract][Full Text] [Related]
18. CFTR activation suppresses glioblastoma cell proliferation, migration and invasion.
Zhong X; Chen HQ; Yang XL; Wang Q; Chen W; Li C
Biochem Biophys Res Commun; 2019 Jan; 508(4):1279-1285. PubMed ID: 30573361
[TBL] [Abstract][Full Text] [Related]
19. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
20. Fractionated Irradiation Enhances Invasion and Migration by Inducing Epithelial-Mesenchymal Transition and Stemness-Like Properties in A549 Cells.
Liu L; Shang M; Song X; Zhang C; Guo W
Ann Clin Lab Sci; 2021 Jul; 51(4):521-528. PubMed ID: 34452890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
